Welcome to the website of the PRECIOUS project!

Stroke is the world’s second largest cause of death and the third cause of long-term disability. The annual costs for stroke care in Europe are currently estimated at € 64.1 billion. Elderly patients have a high risk of complications after stroke, such as infections or fever. These complications are strongly associated with a higher risk of death or dependency. Currently, they are treated only after their occurrence.

 

The PRECIOUS project seeks to find out whether a pharmacological strategy to prevent these complications can reduce the risk of death or long-term disability. PRECIOUS will recruit 3800 patients in 80 hospitals to the study. Patients aged 66 years or older will be randomised to a strategy to prevent complications in the first four days of their hospitalisation, or to standard care. This simple and generally available treatment strategy has the potential to lead to an annual reduction of over 25,000 elderly Europeans being dead or dependent as a result of stroke, at very low costs.

 

This website contains further details undefinedabout the project as well as the undefinedconsortium members. You will also find a section undefinedfor patients and information on undefineddissemination and media issues. Please undefinedcontact us with any questions regarding the project.

Randomisation and eCRF

PRECIOUS Partners

PRECIOUS Partners
Search
Home
Menu
Top

Newsletter Subscription

Please fill in the information of your subscription.

 

You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

The PRECIOUS consortium met at ESOC 2016 in Barcelona. Read more

Social Media

PRECIOUS Twitter